Midterm Outcomes of the Self-Expanding Navitor Transcatheter Heart Valve: A Systematic Review and Meta-Analysis.

ABSTRACT: •A 19-study meta-analysis (7743 ​patients) found high Navitor technical/device success.•≥Moderate PVL was low: 1.3% at 30 days and 0.6% at 1 year.•Pacemaker implantation was 16.7% at 30 days and 20.4% at 1 year.•Thirty-day outcomes were favorable: all-cause mortality 1.5% and stroke 1.7%.

SUBMITTER: Samimi S 

PROVIDER: S-EPMC12741374 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature